U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C17H32O4
Molecular Weight 300.4336
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ROCCELLIC ACID

SMILES

CCCCCCCCCCCC[C@H]([C@H](C)C(O)=O)C(O)=O

InChI

InChIKey=CADNMISJDLVPCK-LSDHHAIUSA-N
InChI=1S/C17H32O4/c1-3-4-5-6-7-8-9-10-11-12-13-15(17(20)21)14(2)16(18)19/h14-15H,3-13H2,1-2H3,(H,18,19)(H,20,21)/t14-,15+/m0/s1

HIDE SMILES / InChI

Molecular Formula C17H32O4
Molecular Weight 300.4336
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Description
Curator's Comment: The description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/27765373

Roccellic acid is a species of fat acid extracted from Roccella phycopsis. Roccellic acid is insoluble in dilute mineral acids, but soluble in alkalies. Roccellic acid has marked antibacterial activity against the oral bacteria, S. gordonii, and P. gingivalis.

Originator

Sources: Scientific Proceedings of the Royal Dublin Society, Series A (1937), 21, 557-66

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
Antibacterial activities of natural lichen compounds against Streptococcus gordonii and Porphyromonas gingivalis.
2017-09
Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
Streptococcus gordonii DL1 and Porphyromonas gingivalis ATCC 33277 were used for activity evaluation. According to Clinical and Laboratory Standards Institute (CLSI) [25], the compounds were 1:2 serially diluted in BHI in a sterile 96-well plate (untreated, flat bottom, with lid, Evergreen Scientific) starting from their initial concentrations. Each well was then inoculated with 3 × 10^7 CFU/mL of S. gordonii and incubated for 24 h or P. gingivalis and incubated for 48 h. The solvents used to prepare the compounds were also tested on the bacteria. After that, the minimal inhibitory concentration (MIC), defined as the minimal concentration able to inhibit the visible bacterial growth, was determined as the clear well having the smallest concentration. All the clear wells were then plated on blood Columbia agar and incubated for 24 h as needed by S. gordonii or for 5 days as required by P. gingivalis. Finally, the minimal bactericidal concentration (MBC), corresponding to the lowest compound concentration killing the bacteria in the well, is determined from the Petri-plate showing no colonies and inoculated from the well with the lowest compound concentration.
Substance Class Chemical
Created
by admin
on Mon Mar 31 22:25:01 GMT 2025
Edited
by admin
on Mon Mar 31 22:25:01 GMT 2025
Record UNII
AEL38V7F67
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ROCCELLIC ACID
MI  
Common Name English
NSC-249985
Preferred Name English
(+)-ROCCELLIC ACID
Common Name English
ROCCELLIC ACID, (+)-
Common Name English
BUTANEDIOIC ACID, 2-DODECYL-3-METHYL-, (2R,3S)-
Systematic Name English
ROCCELLIC ACID [MI]
Common Name English
SUCCINIC ACID, 2-DODECYL-3-METHYL-, (2R,3S)-
Systematic Name English
Code System Code Type Description
PUBCHEM
11449446
Created by admin on Mon Mar 31 22:25:01 GMT 2025 , Edited by admin on Mon Mar 31 22:25:01 GMT 2025
PRIMARY
EPA CompTox
DTXSID90952266
Created by admin on Mon Mar 31 22:25:01 GMT 2025 , Edited by admin on Mon Mar 31 22:25:01 GMT 2025
PRIMARY
CAS
29838-46-8
Created by admin on Mon Mar 31 22:25:01 GMT 2025 , Edited by admin on Mon Mar 31 22:25:01 GMT 2025
PRIMARY
FDA UNII
AEL38V7F67
Created by admin on Mon Mar 31 22:25:01 GMT 2025 , Edited by admin on Mon Mar 31 22:25:01 GMT 2025
PRIMARY
NSC
249985
Created by admin on Mon Mar 31 22:25:01 GMT 2025 , Edited by admin on Mon Mar 31 22:25:01 GMT 2025
PRIMARY
MERCK INDEX
m9643
Created by admin on Mon Mar 31 22:25:01 GMT 2025 , Edited by admin on Mon Mar 31 22:25:01 GMT 2025
PRIMARY Merck Index